OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 162 filers reported holding OREXIGEN THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $49,000 | -23.4% | 113,000 | 0.0% | 0.00% | -33.3% |
| Q1 2016 | $64,000 | -91.5% | 113,000 | -74.2% | 0.01% | -88.5% |
| Q4 2015 | $753,000 | -71.2% | 438,000 | -64.6% | 0.05% | -76.1% |
| Q3 2015 | $2,612,000 | -60.9% | 1,238,000 | -8.3% | 0.22% | -46.0% |
| Q2 2015 | $6,683,000 | -53.2% | 1,350,000 | -25.9% | 0.40% | -39.8% |
| Q1 2015 | $14,266,000 | +34.5% | 1,822,000 | +4.1% | 0.67% | -5.0% |
| Q4 2014 | $10,605,000 | +42.3% | 1,750,000 | 0.0% | 0.71% | +59.4% |
| Q3 2014 | $7,455,000 | +82.8% | 1,750,000 | +165.1% | 0.44% | +76.5% |
| Q2 2014 | $4,079,000 | – | 660,040 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |